East Coast Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-31,780
Closed -$2.03M 100
2016
Q1
$2.03M Hold
31,780
1.08% 33
2015
Q4
$2.19M Hold
31,780
1.2% 31
2015
Q3
$1.88M Hold
31,780
1.17% 34
2015
Q2
$2.12M Hold
31,780
1.13% 38
2015
Q1
$2.05M Buy
31,780
+322
+1% +$20.2K 1.09% 38
2014
Q4
$1.86M Hold
31,458
1.02% 39
2014
Q3
$1.61M Hold
31,458
0.92% 41
2014
Q2
$1.53M Hold
31,458
0.84% 43
2014
Q1
$1.63M Buy
31,458
+1
+0% +$53 0.95% 40
2013
Q4
$1.67M Hold
31,457
0.98% 40
2013
Q3
$1.46M Buy
31,457
+861
+3% +$37.8K 0.95% 42
2013
Q2
$1.37M Buy
+30,596
New +$1.33M 0.74% 47

Other funds holding BMY

East Coast Asset Management's BMY Position: Q2 2016 in Review

East Coast Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2016, closing a stake of 31,780 shares — an estimated $2.03M sold.

East Coast Asset Management first reported a position in BMY in Q2 2013 and held it in 12 quarters. The position peaked at $2.19M in Q4 2015. 1,576 funds tracked by Wall St. Rank hold BMY as of Q2 2016.

  • East Coast Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2016 after selling out during the quarter.
  • East Coast Asset Management sold 31,780 Bristol-Myers Squibb shares in Q2 2016, an estimated $2.03M.
  • East Coast Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 12 quarters.
  • East Coast Asset Management's Bristol-Myers Squibb position peaked at $2.19M in Q4 2015.
  • 1,576 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2016.

Based on East Coast Asset Management's 13F filing for Q2 2016, filed 9 Aug 2016.